A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders

David A. Geier, Janet K. Kern, Georgia Davis, Paul G. King, James Adams, John L. Young, Mark R. Geier

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences